echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Heart experts call for early detection, early treatment, and improved access to innovative drugs for atrial fibrillation

    Heart experts call for early detection, early treatment, and improved access to innovative drugs for atrial fibrillation

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 26, the latest analysis of the EAST-AFNET 4 study published in the leading cardiovascular journal JACC confirmed that early rhythm control can reduce the risk of stroke in patients with atrial fibrillation (hereinafter referred to as "atrial fibrillation", AF.


    Pay attention to atrial fibrillation, don't let stroke take advantage of it

    Atrial fibrillation is when the heart beats out of its normal rhyth.


    Early rhythm control significantly improves quality of life in patients with atrial fibrillation

    At present, rhythm control in patients with atrial fibrillation can be achieved clinically through drug therapy, radiofrequency ablation, and electrical cardioversion, which significantly reduces the incidence of serious complication.


    Professor Dong Yugang from the First Affiliated Hospital of Sun Yat-Sen University said: "If it is a new-onset atrial fibrillation patient with underlying heart disease, we usually give priority to drug treatment, using antiarrhythmic drugs to control atrial fibrillation and enable the patient to recove.


    The results of the prespecified analysis of the EAST-AFNET 4 study recently published by the authoritative journal JACC in the cardiovascular field[ii] suggest that early rhythm control can reduce the three different manifestations of first-diagnosed atrial fibrillation, paroxysmal atrial fibrillation and persistent atrial fibrillation risk of cardiovascular death, stroke, hospitalization for heart failure and acute coronary syndrome in patients with atrial fibrillatio.


    Professor Dong Yugang pointed out: "Clinically, when a patient has symptoms or begins to feel uncomfortable, we all recommend that the patient receive treatment as soon as possibl.


    Improve access to new medicines and benefit more patient groups

    Since the new antiarrhythmic drug dronedarone hydrochloride tablets was launched in the United States and Europe in 2009, more than 15 million patients with atrial fibrillation have used dronedarone hydrochloride tablets worldwid.


    Dronedarone Hydrochloride Tablets are structurally optimized on the basis of amiodaron.


    Professor Dong Yugang pointed out, "At present, there are not many drugs to choose from in Chin.


    The successful launch of dronedarone hydrochloride tablets in China provides a new long-acting and safe drug choice for early rhythm control in patients with atrial fibrillatio.


    About the disease status of atrial fibrillation in China

    According to the latest epidemiological data, there are more than 20 million patients with atrial fibrillation in Chin.


    On July 26, the latest analysis of the EAST-AFNET 4 study published in the leading cardiovascular journal JACC confirmed that early rhythm control can reduce the risk of stroke in patients with atrial fibrillation (hereinafter referred to as "atrial fibrillation", AF.


           Pay attention to atrial fibrillation, don't let stroke take advantage of it

      Pay attention to atrial fibrillation, don't let stroke take advantage of it

           Atrial fibrillation is when the heart beats out of its normal rhyth.


           Early rhythm control significantly improves quality of life in patients with atrial fibrillation

        Early rhythm control significantly improves quality of life in patients with atrial fibrillation

           At present, rhythm control in patients with atrial fibrillation can be achieved clinically through drug therapy, radiofrequency ablation, and electrical cardioversion, which significantly reduces the incidence of serious complication.


           Professor Dong Yugang from the First Affiliated Hospital of Sun Yat-Sen University said: "If it is a new-onset atrial fibrillation patient with underlying heart disease, we usually give priority to drug treatment, using antiarrhythmic drugs to control atrial fibrillation and enable the patient to recove.


           The results of the prespecified analysis of the EAST-AFNET 4 study recently published by the authoritative journal JACC in the cardiovascular field[ii] suggest that early rhythm control can reduce the three different manifestations of first-diagnosed atrial fibrillation, paroxysmal atrial fibrillation and persistent atrial fibrillation risk of cardiovascular death, stroke, hospitalization for heart failure and acute coronary syndrome in patients with atrial fibrillatio.


           Professor Dong Yugang pointed out: "Clinically, when a patient has symptoms or begins to feel uncomfortable, we all recommend that the patient receive treatment as soon as possibl.
    Our doctor will consider how to choose the drug according to the specific situation of thepatien.
    The patient also needs to give feedback on the medication in tim.
    It is convenient for doctors to adjust the choice and dosage of drug.
    Special attention should not be given to stop taking drugs because you have no symptoms and feel that you are in good physical conditio.
    This may lead to serious events such as strok.
    Therefore, we must pay attention to atrial fibrillatio.
    early prevention and treatmen.

           Improve access to new medicines and benefit more patient groups

       Improve access to new medicines and benefit more patient groups

           2009,1500
    。20211222,(NMPA),

           ,,、,,
    。,158[iii],25%[iv],、
    。2020 ESC [v]

           ,“,,,,
    。,
    。,,,
    。,,,
    。”

           ,
    。,,,

           About the disease status of atrial fibrillation in China

      About the disease status of atrial fibrillation in China

           According to the latest epidemiological data, there are more than 20 million patients with atrial fibrillation in Chin.
    With the aging of the population, the number of new patients is still risin.
    The standardized prevalence of atrial fibrillation in adults over the age of 45 is about 2.
    , atrial fibrillation has become a major public health problem endangering people's healt.
    Atrial fibrillation significantly increases the risk of adverse outcomes such as stroke and heart failure, seriously affects the quality of life of patients, and even threatens lif.
    In particular, stroke patients with atrial fibrillation are deeply in the dilemma of high medical expenses, many hospitalizations, and long hospitalization days, and bear a heavy economic burde.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.